This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
San Diego-based Arcturus Therapeutics , a developer of RNAi technology, said it has raised $5M in a Series A funding round. According to Arcturus, the funding came from multiple private capital,, high net worth investors from Canada, Japan, and the United States. Names of those capital sources were not announced.
Pasadena-based venture capital firm ArcturusCapital has scored an exit out of its portfolio this morning, as Milpitas, California-based Pliant Technology was acquired by SanDisk in a deal worth $327M. Arcturus first invested in Pliant in 2007. SanDisk is a major manufacturer of flash memory.
San Diego-based Arcturus Therapeutics , which is developing RNAi therapeutics to treat disease, said this morning that it has raised $1.3M Arcturus Therapeutics is headed by Joseph E. Arcturus Therapeutics is headed by Joseph E. arcturus therapeutics venture capital rnai lifescience biotech' and Canada.
Prolacta is venture funded by Alta Ventures, DFJ Frontier, ArcturusCapital, DFJ Mercury, Funk Ventures, Phillip Capital, Gideon Hixon Fund, and Draper Associates L.P. The firm said it will commit a minimum amount of $25,000 annually to fund programs at Komen.
San Diego-based Arcturus Therapeutics has received up to $220M in additional financial commitments from the country of Singapore, after receiving positive Phase 1/2 study results on one of its compounds.
Los Angeles-based Arcturus, a developer of 3D video editing tools, said Wednesday afternoon that it has raised $11M in a Series A funding round. The funding was led by Cloudtree Ventures, and also included Autodesk and Epic Games. The startup is led by CEO Kamal Mistry.
Prolacta is venture backed by such companies as Health Evolution Partners, Alta Partners, DFJ Frontier, ArcturusCapital, DFJ Mercury, Funk Ventures, Phillip Capital, Gideon Hixon Fund, and Draper Associates. The use of human milk helps avoid serious side effects that can occur with premature infants if they use cow-based milk.
TrueCar is venture backed by backed by USAA, Capricorn Investment Group, Upfront Ventures, Anthem Ventures, Vulcan Capital Growth Equity, Peppy Capital Partners, Arcturus Venture Capital, along with others. TrueCar is trading on the NASDAQ Global Select Market as TRUE. READ MORE>>.
The round was led by Prospector Equity Capital and ArcturusCapital, and also included the Pasadena Angels and Tech Coast Angels. Monrovia-based Ondax , a manufacturer of volume holographic grating filters and lasers, said Tuesday that it has officially closed its $2.2M, Series E funding round.
The firm said it has scored Series A funding from Zag, Anthem Venture Partners, Global Retail Partners, Capricorn, Capital One Auto Finance, ARcturusCapital, Scott Painter, and co-founder Tom Taira. According to TrueCar, it will provide information about new car pricing, using the actual price people have paid for cars.
ONDAX is backed by ArcturusCapital, Prospector Equity Capital, and others. Moser is a native of Switzerland, and will remain as Chief Technology Officer at the firm. Heyler was most recently at Newport Corporation.
The firm is venture backed by Anthem Ventures, ArcturusCapital, Capital One, Capricorn Management, and GRP Partners. Painter is best known for being the founder and CEO of CarsDirect.com, but is also heavily involved in local startups such as SharesPost, and other firms through his BrightHouse business incubator.
Dr. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom. Tags: sorrento therapeutics biotech venture capital lifescience aviaradx. The firm is headed by Antonius Schuh, who serves as founding chairman and CEO; the firm's CFO is Steve Zaniboni.
TrueCar is venture backed by Zag, Anthem Venture Partners, Global Retail Partners, Capricorn, Capital One Auto Finance, and ArcturusCapital. The new service is free, and is based on automotive transactions within the last four weeks. READ MORE>>.
Zag has previously received funding from Anthem Ventures, ArcturusCapital, Capital One, Capricorn Management, GRP Partners, and the Tech Coast Angels. Tags: automobile venture auto capital funding. The firm recently spun out True Car, an automotive pricing information site. READ MORE>>.
Zag is venture backed by Anthem Ventures, ArcturusCapital, Capital One, Capricorn Management, GRP Partners, and the Tech Coast Angels, along with USAA. Tags: automobile auto venture funding capital. The firm recently spun out True Car, an automotive pricing information site. READ MORE>>.
The round was led by Rincon Venture Partners, and also included ArcturusCapital and Momentum Venture Management. According to Momentum Venture Management, which announced the deal, the round has not yet closed and is adding a "small amount" of additional capital before closing the round. in a Series A funding round.
Zag has previously received venture capital from such firms as Anthem Ventures, GRP Partners, the Tech Coast Angels, Capricorn Management, Capital One, and ArcturusCapital. The firm did not say what drove the growth, and did not provide any financial details on its sales or profitability. READ MORE>>.
Zag has now signed up 14 AAA motor clubs, and also provides its technology to Capital One Auto Finance, Overstock.com, and other sites. Zag is headed by former CarsDirect CEO Scott Painter, and is venture backed by Anthem Venture Partners, Capital One Auto Finance, GRP Partners, ArcturusCapital, Callaway Cars and the Skoll Fund.
The firm is backed by Anthem Venture Partners, Capital One Auto Finance, GRP Partners, ArcturusCapital, Callaway Cars and the Skoll Fund. Zag develops software used for configuring and pricing new and used automobiles, which it provides on a white-label basis to affinity buying programs. READ MORE>>
Zag is venture backed by Anthem Venture Partners, USAA, GRP Partners, ArcturusCapital, Callaway Cars and the Skoll Fund. Zag's technology differs from other similar programs in that it offers fully detailed pricing on exact options, rather than just feeding leads into a dealership's fleet or online department. READ MORE>>.
The public markets are moving erratically, but Alnylam Pharmaceuticals showed this week that selling equity isn’t the only way for biotech companies to raise cash. Late last year Alnylam (NASDAQ: ALNY ) began exploring potential royalty deals for inclisiran, a drug that uses RNA interference to lower cholesterol.
Biotech startups rolled in cash this week. By our count, investors put more than $800 million into life-sciences startups in four days. The money came from a wide range of backers, not just traditional biotech venture firms. It’s early yet in 2018, but the current count could put life-sciences companies on pace to bust past last year’s $17.6
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content